Related references
Note: Only part of the references are listed.Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer
Marina Frana de Resende et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53
Tzu-Ching Kuo et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2012)
Defining NOTCH3 Target Genes in Ovarian Cancer
Xu Chen et al.
CANCER RESEARCH (2012)
Notch Signaling Modulates Hypoxia-Induced Neuroendocrine Differentiation of Human Prostate Cancer Cells
Giovanna Danza et al.
MOLECULAR CANCER RESEARCH (2012)
cis-Expression QTL Analysis of Established Colorectal Cancer Risk Variants in Colon Tumors and Adjacent Normal Tissue
Lenora W. M. Loo et al.
PLOS ONE (2012)
Gene expression profiles and differential cytoglobin expression in atrophy and adenocarcinoma of the prostate
Ashish P. Mogal et al.
PROSTATE (2012)
Prognostic significance of ATM and cyclin B1 in pancreatic neuroendocrine tumor
Jae Uk Shin et al.
TUMOR BIOLOGY (2012)
In situ RHAMM protein expression in acute myeloid leukemia blasts suggests poor overall survival
Alexandar Tzankov et al.
ANNALS OF HEMATOLOGY (2011)
Prognostic impact of CD168 expression in gastric cancer
Sumiya Ishigami et al.
BMC CANCER (2011)
Identification of Gene Markers Associated With Aggressive Meningioma by Filtering Across Multiple Sets of Gene Expression Arrays
Jourdan E. Stuart et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
A Tri-Marker Proliferation Index Predicts Biochemical Recurrence after Surgery for Prostate Cancer
Sameer Malhotra et al.
PLOS ONE (2011)
Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy
Michael Giesing et al.
BJU INTERNATIONAL (2010)
The relevance of a hypoxic tumour microenvironment in prostate cancer
Grant D. Stewart et al.
BJU INTERNATIONAL (2010)
The Ability of Biomarkers to Predict Systemic Progression in Men with High-Risk Prostate Cancer Treated Surgically Is Dependent on ERG Status
R. Jeffrey Karnes et al.
CANCER RESEARCH (2010)
Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and Survival
Aurelien de Reynies et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Generating specificity and diversity in the transcriptional response to hypoxia
Urban Lendahl et al.
NATURE REVIEWS GENETICS (2009)
An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia
Yair Benita et al.
NUCLEIC ACIDS RESEARCH (2009)
RHAMM (CD168) Is Overexpressed at the Protein Level and May Constitute an Immunogenic Antigen in Advanced Prostate Cancer Disease
Kilian M. Gust et al.
NEOPLASIA (2009)
Identification of prognostic biomarkers for prostate cancer
Farhad Kosari et al.
CLINICAL CANCER RESEARCH (2008)
Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy
John C. Cheville et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gene expression analysis of hematopoietic progenitor cells identifies Dlg7 as a potential stem cell gene
Kristbjorn Orri Gudmundsson et al.
STEM CELLS (2007)
Hypoxia, gene expression, and metastasis
Denise A. Chan et al.
CANCER AND METASTASIS REVIEWS (2007)
Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy
Lourdes A. Gomez et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancer
Dagmar M. Kube et al.
BMC MOLECULAR BIOLOGY (2007)
Low-level TOP2A amplification in prostate cancer is associated with HER2 duplication, androgen resistance, and decreased survival
Amanda J. Murphy et al.
CANCER RESEARCH (2007)
HURP controls spindle dynamics to promote proper interkinetochore tension and efficient kinetochore capture
Jim Wong et al.
JOURNAL OF CELL BIOLOGY (2006)
An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: Implications for radioresistance
Dawn M. Carnell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
HURP is part of a ran-dependent complex involved in spindle formation
MD Koffa et al.
CURRENT BIOLOGY (2006)
Enhanced transformation and chemosensitivity of NIH3T3 cells transduced with hepatoma up-regulated protein
YC Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Defining aggressive prostate cancer using a 12-gene model
Tarek A. Bismar et al.
NEOPLASIA (2006)
Gleason grading and prognostic factors in carcinoma of the prostate
PA Humphrey
MODERN PATHOLOGY (2004)
KIAA0008 gene is associated with invasive phenotype of human hepatocellular carcinoma - functional analysis
L Zhao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Identification of a novel cell cycle regulated gene, HURP, overexpressed in human hepatocellular carcinoma
AP Tsou et al.
ONCOGENE (2003)
Potential molecular marker for detecting transitional cell carcinoma
AW Chiu et al.
UROLOGY (2002)
Gene expression correlates of clinical prostate cancer behavior
D Singh et al.
CANCER CELL (2002)
Characterization of a novel human cell-cycle-regulated homologue of Drosophila dlg1
S Bassal et al.
GENOMICS (2001)
Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy
ML Blute et al.
JOURNAL OF UROLOGY (2001)
Share Paper
